Inflammatory Bowel Diseases

Title Publication Date Language Citations
Pediatric modification of the Montreal classification for inflammatory bowel disease2011/06/01English1,050
Long-Term Evolution of Disease Behavior of Crohn's Disease2002/07/01English946
Low counts of Faecalibacterium prausnitzii in colitis microbiota2009/08/01English850
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends2011/01/01English662
A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 19982000/02/01English601
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease2012/12/01English598
Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis2008/12/01English593
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis2009/03/01English560
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease2009/09/01English504
Update on the incidence and prevalence of Crohnʼs disease and ulcerative colitis in Olmsted County, Minnesota, 1940–20002007/03/01English449
Development of the Crohnʼs disease digestive damage score, the Lémann score2011/06/01English438
Intestinal barrier dysfunction in inflammatory bowel diseases2009/01/01English427
Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases2011/01/01English426
Importance of disrupted intestinal barrier in inflammatory bowel diseases2011/01/01English399
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management2009/07/01English387
Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host2011/09/01English380
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: A KASID study2008/04/01English379
Magnetic resonance imaging for evaluation of Crohnʼs disease2011/08/01English370
World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 20102010/01/01English353
Mechanisms of action of probiotics: Recent advances2009/02/01English346
Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings2008/01/01English333
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents2007/11/01English332
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohnʼs disease2009/05/01English328
C-Reactive Protein as a Marker for Inflammatory Bowel Disease2004/09/01English324
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis2011/06/01English317
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#2007/12/01English306
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease2006/06/01English303
Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance2007/08/01English295
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study2001/05/01English283
Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population-Based Study from Copenhagen, Denmark2007/04/01English281